BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 6233454)

  • 1. Potentiation of alpha-naphthyl thiourea-induced lung injury by prostaglandin E1 and platelet depletion.
    Fantone JC; Kunkel RG; Kinnes DA
    Lab Invest; 1984 Jun; 50(6):703-10. PubMed ID: 6233454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prostaglandin E1 on platelet attenuation of oxidant-induced edema in isolated rabbit lungs.
    Heffner JE; Baron DA
    J Lab Clin Med; 1990 Dec; 116(6):797-804. PubMed ID: 2246556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate and drug-induced resistance to acute lung damage caused in rats by alpha-naphthyl thiourea (ANTU) and related compounds.
    van den Brenk HA; Kelly H; Stone MG
    Br J Exp Pathol; 1976 Dec; 57(6):621-36. PubMed ID: 137734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of dexmedetomidine in a rat model of α-naphthylthiourea-induced acute lung injury.
    Hanci V; Yurdakan G; Yurtlu S; Turan IÖ; Sipahi EY
    J Surg Res; 2012 Nov; 178(1):424-30. PubMed ID: 22445456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-hypoxaemic pulmonary oedema induced by alpha-naphthyl thiourea in the rat.
    Vivet P; Brun-Pascaud M; Mansour H; Pocidalo JJ
    Br J Exp Pathol; 1983 Aug; 64(4):361-6. PubMed ID: 6412736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine modulates inducible nitric oxide synthase expression and reduces pulmonary oedema induced by alpha-naphthylthiourea.
    Comert M; Sipahi EY; Ustun H; Isikdemir F; Numanoglu G; Barut F; Altunkaya H; Ozer Y; Niyazi Ayoglu F; Sipahi TH; Tekin IO; Banoglu ZN
    Eur J Pharmacol; 2005 Mar; 511(2-3):183-9. PubMed ID: 15792787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory effects of prostaglandin E1: in vivo modulation of the formyl peptide chemotactic receptor on the rat neutrophil.
    Fantone JC; Marasco WA; Elgas LJ; Ward PA
    J Immunol; 1983 Apr; 130(4):1495-7. PubMed ID: 6300229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of alpha-naphthylthiourea-induced pulmonary edema with fructose-1,6-diphosphate.
    Markov AK; Causey AL; Didlake RH; Lemos LB
    Exp Lung Res; 2002 Jun; 28(4):285-99. PubMed ID: 12042031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the endothelin receptor antagonist tezosentan on alpha-naphthylthiourea-induced lung injury in rats.
    Atalay F; Yurdakan G; Yilmaz-Sipahi E
    Kaohsiung J Med Sci; 2012 Feb; 28(2):72-8. PubMed ID: 22313533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasodilator actions of prostaglandin 6-keto-E1 in the pulmonary vascular bed.
    Hyman AL; Kadowitz PJ
    J Pharmacol Exp Ther; 1980 Jun; 213(3):468-72. PubMed ID: 7193724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological effects of (+/-)-11-deoxy, 16-phenoxy-prostaglandin E1 derivatives in the cardiovascular system.
    Banerjee AK; Tuffin DP; Walker JL
    Br J Pharmacol; 1985 Jan; 84(1):71-80. PubMed ID: 3884073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired responsiveness of platelets from patients with stable angina pectoris to antiaggregating and cyclicAMP-elevating effects of prostaglandin E1.
    Chirkov YY; Chirkova LP; Sage RE; Horowitz JD
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):961-6. PubMed ID: 7564342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of parenteral lipid emulsion-induced hyperlipidemia on prostaglandin E1 modulation of platelet function.
    Saladino CF; Kosacolsky-Singer C; Fox R; Nethala V; Feffer SE; Jonas EA
    Artery; 1993; 20(6):303-13. PubMed ID: 8010886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended lung preservation with platelet-activating factor-antagonist TCV-309 in combination with prostaglandin E1.
    Qayumi AK; English JE; Duncan S; Ansley DM; Pearson B; Nikbakht-Sangari M; Sammartino C; Fradet G
    J Heart Lung Transplant; 1997 Sep; 16(9):946-55. PubMed ID: 9322146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the mechanism of toxicity and of development of tolerance to the pulmonary toxin, alpha-naphthylthiourea (ANTU).
    Boyd MR; Neal RA
    Drug Metab Dispos; 1976; 4(4):314-22. PubMed ID: 8285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyamine synthesis in rat lungs injured with alpha-naphthylthiourea.
    Olson JW; Gebb SA; Orlinska U; Gillespie MN
    Toxicology; 1989 May; 55(3):317-26. PubMed ID: 2497556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of rapid reperfusion-induced lung injury with prostaglandin E1 during the initial period of reperfusion.
    DeCampos KN; Keshavjee S; Liu M; Slutsky AS
    J Heart Lung Transplant; 1998 Nov; 17(11):1121-8. PubMed ID: 9855452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergism of (15 S)-15-methyl-prostaglandin E1 with either azathioprine or prednisolone on the survival of heart allografts in rats.
    Kort WJ; Bonta IL; Adolfs MJ; Westbroek DL
    Prostaglandins Leukot Med; 1982 Jun; 8(6):661-4. PubMed ID: 7051048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of acute inflammation by 15 methyl prostaglandin E1.
    Tate GA; Mandell BF; Schumacher HR; Zurier RB
    Lab Invest; 1988 Aug; 59(2):192-9. PubMed ID: 2841538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of pentobarbital, thiopental and urethane on lung oedema induced by alpha-naphthythiourea (ANTU).
    Sipahi E; Ustün H; Niyazi Ayoglu F
    Pharmacol Res; 2002 Mar; 45(3):235-9. PubMed ID: 11884221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.